Inhaled Treprostinil in Pulmonary Hypertension


Next in Medicine

Aaron Waxman discusses research into patients with pulmonary hypertension due to interstitial lung disease and the effects of inhaled treprostinil.  Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.

Image courtesy of Aaron Waxman

Image courtesy of interviewee. February 18, 2021

Log-in or Sign-up to Faculti
Currently viewing this subject insight as a guest. You have insight(s) remaining for this month. Login to view 8000+ figures on the platform.
Copyright © Faculti Media Limited 2013 - 2024. All rights reserved.
error: